Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1

Rheumatology International

Volumn 30, Issue 6, 2010, Pages 775-778

  Ferraz Chaoui, Ana Karina ^a   Atta, Ajax Mercês ^b   Atta, Maria Luiza Sousa ^b   Galvão Castro, Bernardo ^a   Santiago, Mittermayer B ^a  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Autoantibodies; HTLV 1; Keratoconjunctivitis sicca; Proviral load

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; LA ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMORAL IMMUNITY; KERATOCONJUNCTIVITIS SICCA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROVIRUS; VIRUS LOAD;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIGENS, BACTERIAL; AUTOANTIBODIES; BIOLOGICAL MARKERS; BRAZIL; COHORT STUDIES; FEMALE; HTLV-I INFECTIONS; HUMANS; IMMUNITY, HUMORAL; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; PROVIRUSES; RHEUMATOID FACTOR; VIRAL LOAD;

EID: 77951024389     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1066-5     Document Type: Article

References (32)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415-7419
2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058-6068
3. Galvao-Castro B, Loures L, Rodriques LG et al (1997) Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37(2):242-243
4. Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B (2003) HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune DeWc Syndr 34(5):527-531
5. Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79(6):2031-2035 (Pubitemid 12088563)
6. Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407-410
7. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M (1989) Chronic inXammatory arthropathy associated with HTLV-I. Lancet 1(8635):441
8. Ijichi S, Matsuda T, Maruyama I, Ijichi S et al (1990) Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 49(9):718-721
9. Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989) HTLV-1 and polymyositis in Jamaica. Lancet 2(8673):1184-1187
10. Eguchi K, Matsuoka N, Ida H et al (1992) Primary Sjogren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51(6):769-776
11. Terada K, Katamine S, Eguchi K et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren's syndrome. Lancet 344(8930):1116-1119
12. Mochizuki M, Watanabe T, Yamaguchi K et al (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83(3):236-239
13. Merle H, Cabre P, Merle S, Gerard M, Smadja D (2001) A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients. Am J Ophthalmol 131(3):305-308
14. Buggage RR, Levy-Clarke GA, Smith JA (2001) New corneal Wndings in human T-cell lymphotrophic virus type 1 infection. Am J Ophthalmol 131(3):309-313
15. Merle H, Smadja D, Le Hoang P, Merle H, Smadja D, Le Hoang P et al (1996) Ocular manifestations in patients with HTLV-I associated infection-a clinical study of 93 cases. Jpn J Ophthalmol 40(2):260-270
16. Merle H, Cabre P, Olindo S, Merle S, Smadja D (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 134(2):190-195
17. Nakamura H, Eguchi K, Nakamura T et al (1997) High prevalence of Sjogren's syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56(3):167-172
18. Vitali C, Bombardieri S, Moutsopoulos HM et al (1996) Assessment of the European classiWcation criteria for Sjogren's syndrome in a series of clinically deWned cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's syndrome. Ann Rheum Dis 55(2):116-121
19. Dehee A, Cesaire R, Desire N et al (2002) Quantitation of HTLVI proviral load by a TaqMan real-time PCR assay. J Virol Methods 102(1-2):37-51
20. Green JE, Hinrichs SH, Vogel J, Jay G (1989) Exocrinopathy resembling Sjogren's syndrome in HTLV-1 tax transgenic mice. Nature 341(6237):72-74
21. Hida A, Kawabe Y, Kawakami A et al (1999) HTLV-I associated Sjogren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren's syndrome. Ann Rheum Dis 58(5):320-322
22. Nakamura H, Kawakami A, Tominaga M et al (2000) Relationship between Sjogren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med 135(2):139-144
23. Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol 21(5):656-660
24. Merle H, Cabre P, Smadja D, Josset P, Landau M, Vernant JC (1999) Sicca syndrome and HTLV-I-associated myelopathy/tropical spastic paraparesis. Jpn J Ophthalmol 43(6):509-512
25. Pinheiro SR, Lana-Peixoto MA, Proietti AB et al (1995) HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjogren's syndrome. Arq Neuropsiquiatr 53(4):777-781
26. Moraes HV Jr, Branco RL, Pinto CMS, Dantas MM, Fiszman R (1995) HTLV-I e Uveíte. Revista Brasileira de Oftalmologia 54(12):39-42
27. Pinheiro SR, Martins-Filho AO, Ribas JG et al (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142(5):811-815
28. Giozza SP, Santos SB, Martinelli M, Porto MA, Muniz AL, Carvalho EM (2008) Salivary and lacrymal gland disorders and HTLV-1 infection. Rev Stomatol Chir Maxillofac 109(3):153-157
29. Santiago M, Crusoé EQ, Matos AV (2002) Manifestações reumatológicas associadas à infecção pelo HTLV-I. Rev Bras Reumatol 42(5):306-310
30. Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T (1995) Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 79(3):270-276
31. Best I, Adaui V, Verdonck K et al (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol 146(2):226-233
32. Montanheiro PA, Oliveira AC, Posada-Vergara MP et al (2005) Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLVI- associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res 38(11):1643-1647